Literature DB >> 10471353

Induction of cardiac nitric oxide synthase 2 in rats exposed to chronic hypoxia.

P Rouet-Benzineb1, S Eddahibi, B Raffestin, M Laplace, S Depond, S Adnot, B Crozatier.   

Abstract

Induction of nitric oxide synthase (NOS2, also designated as iNOS) in the heart is known to occur in response to various stimuli. It is not known, however, whether in vivo hypoxia leads to cardiac NOS2 induction. We thus investigated the effects of normobaric hypoxia (10% O(2)for 8, 15 and 21 days) on NOS2 protein expression and enzyme activity in rat right ventricle (RV) and left ventricle (LV). Chronic hypoxia induced RV hypertrophy: the RV weight to body weight ratio was increased by 45% upon 15 days of exposure, with no change thereafter and no change in left ventricular (LV) weight. Treatment of hypoxic rats with l -NAME for 1 month decreased pulmonary artery pressure and RV hypertrophy compared to hypoxic non-treated rats. NOS2 activity detected by [(3)H]l -arginine to [(3)H]l -citrulline conversion increased in RV during hypoxia, with a maximum at 15 days (+161% of control rats P<0.05), whereas it increased less (by 60%) in LV. In parallel, after 15 days of hypoxia there was a three-fold increase in NOS2 protein abundance detected by Western blotting using an isoform-specific antibody in the RVs (two-fold increase in the LV). Immunochemistry with the specific antibody demonstrated the expression in cardiomyocytes isolated from both ventricles of normoxic and hypoxic rats. Protein kinase C (PKC) content and activity was unchanged in LV of hypoxic rats, but increased in RV as compared with normoxic rats. These results clearly show that, in the heart, NOS2 is upregulated by hypoxia with an expression in cardiomyocytes of both ventricles. In addition, NOS2 is more inducible in the right hypertrophied ventricle than in the left non-hypertrophied hypoxic ventricle. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471353     DOI: 10.1006/jmcc.1999.1005

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  7 in total

1.  Inducible nitric oxide synthase in the myocard.

Authors:  I B Buchwalow; W Schulze; P Karczewski; M M Kostic; G Wallukat; R Morwinski; E G Krause; J Müller; M Paul; J Slezak; F C Luft; H Haller
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

2.  The ternary complex factor net is downregulated by hypoxia and regulates hypoxia-responsive genes.

Authors:  Christian Gross; Gilles Buchwalter; Hélène Dubois-Pot; Emilie Cler; Hong Zheng; Bohdan Wasylyk
Journal:  Mol Cell Biol       Date:  2007-04-02       Impact factor: 4.272

3.  Postanoxic functional recovery of the developing heart is slightly altered by endogenous or exogenous nitric oxide.

Authors:  J Terrand; E Felley-Bosco; F Courjault-Gautier; A C Rochat; P Kucera; E Raddatz
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

4.  Hypoxic conditioning suppresses nitric oxide production upon myocardial reperfusion.

Authors:  Myoung-Gwi Ryou; Jie Sun; Kevin N Oguayo; Eugenia B Manukhina; H Fred Downey; Robert T Mallet
Journal:  Exp Biol Med (Maywood)       Date:  2008-04-11

5.  Ventricular but not atrial electro-mechanical delay of the embryonic heart is altered by anoxia-reoxygenation and improved by nitric oxide.

Authors:  Philippe Maury; Alexandre Sarre; Jérôme Terrand; Antonio Rosa; Pavel Kucera; Lukas Kappenberger; Eric Raddatz
Journal:  Mol Cell Biochem       Date:  2004-10       Impact factor: 3.396

6.  Upregulation of cardiac NO/NOS system during short-term hypoxia and the subsequent reoxygenation period.

Authors:  A Rus; M L Del Moral; F Molina; M A Peinado
Journal:  Eur J Histochem       Date:  2011-05-17       Impact factor: 3.188

7.  Safflor yellow B reduces hypoxia-mediated vasoconstriction by regulating endothelial micro ribonucleic acid/nitric oxide synthase signaling.

Authors:  Chaoyun Wang; Ying Yang; Miao Li; Xin Liu; Qiaoyun Wang; Wenyu Xin; Hongliu Sun; Qingyin Zheng
Journal:  Oncotarget       Date:  2017-08-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.